Avandia (rosiglitazone) is now approved to be used with insulin in patients with type 2 diabetes
Avandia (rosiglitazone) is now approved to be used with insulin in patients with type 2 diabetes.
Until now, Actos (pioglitazone) was the only glitazone approved for use with insulin.
Adding a glitazone to insulin lowers blood glucose...allowing many patients to reduce their insulin dose.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote